Acurion

Private

Precision oncology technology company developing advanced diagnostic and therapeutic tools for cancer treatment. Combines AI-driven analysis with clinical workflows to enable personalized cancer care at scale.

Founders David Sidransky

CEO David Sidransky

Company

Founded

2024

Headquarters

San Diego, United States

Financials

Total Funding

$4M

Sectors

Artificial Intelligence Healthtech Biotech

www.acurion.com

Funding History

1 round

Seed Apr 3, 2026

$4M

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.